Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation
Open Access
- 1 April 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 120 (1) , 93-100
- https://doi.org/10.1046/j.1365-2249.2000.01186.x
Abstract
HIV type 1 expression was significantly up‐regulated in chronically infected promonocytic cell line (U1) co‐cultured with human umbilical vein endothelial cells (HUVEC). Virus replication, evaluated as supernatant p24 release, was higher when U1 were co‐cultured with IL‐1β‐activated HUVEC than with unstimulated HUVEC. When non‐adherent U1 were removed from co‐cultures, the remaining U1 cells adherent to the endothelial monolayer still showed enhanced HIV replication in comparison with an equal number of U1 cultured alone. While addition of adhesion molecule blocking antibodies (anti‐intercellular adhesion molecule‐1 (ICAM‐1), ‐vascular cell adhesion molecule‐1 (VCAM‐1), ‐CD18 and ‐very late antigen‐4 (VLA‐4)) strongly inhibited adherence of U1 cells to endothelial monolayers, such treatment resulted in only a partial reduction in p24 release. Furthermore, HIV replication in U1 cells was enhanced on culture in HUVEC‐conditioned media. Such data suggest that soluble mediators secreted by endothelial monolayers may modulate HIV‐1 expression. Indeed, addition of cytokine and chemokine antagonists to both U1/HUVEC co‐cultures and to U1 cultured in HUVEC‐conditioned media clearly down‐regulated p24 release. Anti‐IL‐6, anti‐tumour necrosis factor‐alpha (TNF‐α) and, particularly, anti‐MCP‐1 MoAbs reduced p24 release, while anti‐IL‐8 polyclonal antiserum and IL‐1 receptor antagonist (IL‐1Ra) had no significant effect. Thus, the interaction between HUVEC and infected monocytic cells up‐regulates HIV‐1 replication predominantly through production of endothelium‐derived soluble factors including MCP‐1, TNF‐α and IL‐6. This phenomenon may influence the passage of HIV‐1 from latency to productive replication and enhance virus spreading during physiological and/or pathological contact of monocytes with endothelium.Keywords
This publication has 55 references indexed in Scilit:
- Plasma Levels of Monocyte Chemoattractant Protein‐1 but Not Those of Macrophage Inhibitory Protein‐1a and RANTES Correlate with Virus Load in Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1997
- Endothelial Cells as a Target for Antiphospholipid Antibodies: Role of Anti-Beta 2 Glycoprotein I AntibodiesAmerican Journal of Reproductive Immunology, 1997
- Induction of HIV-1 Expression in Chronically Infected Promonocytic Cells Cocultured with Human Lung FibroblastsClinical Immunology and Immunopathology, 1996
- Engagement of Adhesion Molecules (CD18, CD11a, CD45, CD44, and CD58) Enhances Human Immunodeficiency Virus Type 1 Replication in Monocytic Cells through a Tumor Necrosis Factor-Modulated PathwayThe Journal of Infectious Diseases, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.The Journal of Experimental Medicine, 1990
- Role of Mononuclear Phagocytes in the Pathogenesis of Human Immunodeficiency Virus InfectionAnnual Review of Immunology, 1990
- Anti-endothelial cell antibodies in patients withWegener's granulomatosis and micropolyarteritisClinical and Experimental Immunology, 1990
- Activation of HIV gene expression during monocyte differentiation by induction of NF-kBNature, 1989